Tenuifoliside A is primarily studied for its neuroprotective properties. It has shown potential in supporting cognitive function and protecting brain cells from damage associated with neurodegenerative conditions such as Alzheimer's disease. The compound crosses the blood-brain barrier effectively, allowing it to exert direct effects in the central nervous system. Research indicates it may reduce neuroinflammation and inhibit the accumulation of amyloid-beta peptides, which are linked to neuronal damage. Additionally, Tenuifoliside A has demonstrated antidepressant-like effects in animal models, suggesting possible use in treating mood disorders. It is also being explored for its ability to enhance synaptic plasticity and support nerve growth, making it a candidate for development in therapies aimed at brain injury recovery and cognitive enhancement.